Safety and Efficacy of Fingolimod in Japanese Patients with Multiple Sclerosis: Interim Analysis Results from Post-marketing Surveillance

被引：0

作者：

Kira, J. ^{[1
]}

Fujihara, K. ^{[2
]}

Ueda, K. ^{[3
]}

Tajima, T. ^{[4
]}

Ueno, M. ^{[4
]}

Saida, T. ^{[5
,6
,7
]}

机构：

[1] Kyushu Univ, Inst Neurol, Grad Sch Med Sci, Fukuoka 812, Japan

[2] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan

[3] Novartis Pharma KK, Tokyo, Japan

[4] Mitsubishi Tanabe Pharma Corp, Osaka, Japan

[5] Kyoto Min Iren Cent Hosp, Kyoto, Japan

[6] Inst Neurotherapeut, Kyoto, Japan

[7] Kyoto Univ Hosp, Kyoto 606, Japan

来源：

MULTIPLE SCLEROSIS JOURNAL | 2014年 / 20卷 / 07期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P-55

引用

页码：928 / 928

页数：1

共 50 条

[21] Efficacy and Safety of Tolvaptan in Heart Failure Patients With Volume Overload - An Interim Result of Post-Marketing Surveillance in Japan
Kinugawa, Koichiro
Sato, Naoki
Inomata, Takayuki
Shimakawa, Toshiyuki
Iwatake, Noriaki
Mizuguchi, Kazuki
CIRCULATION JOURNAL, 2014, 78 (04) : 844 - 852
[22] Evaluation of the safety and efficacy of recombinant Factor IX (nonacog alfa) in Japanese patients with hemophilia B - The second interim analysis of 304 patients in a post-marketing surveillance study
Amano, Kagehiro
Fukutake, Katsuyuki
Hanabusa, Hideji
Taki, Masashi
Matsushita, Tadashi
Shima, Midori
Sakai, Michio
Yamaguchi, Hiromi
Karumori, Toshiyuki
HAEMOPHILIA, 2014, 20 : 22 - 22
[23] Safety and Efficacy of Ripasudil in Japanese Patients with Glaucoma or Ocular Hypertension: 3-month Interim Analysis of ROCK-J, a Post-Marketing Surveillance Study
Hidenobu Tanihara
Takahiko Kakuda
Tetsuro Sano
Takashi Kanno
Ryosuke Imada
Wataru Shingaki
Ryoji Gunji
Advances in Therapy, 2019, 36 : 333 - 343
[24] Safety and efficacy of regorafenib post-marketing surveillance (PMS) in Japanese patients with metastatic colorectal cancer (mCRC).
Komatsu, Yoshito
Muro, Kei
Yamaguchi, Kensei
Satoh, Taroh
Uetake, Hiroyuki
Yoshino, Takayuki
Nishida, Toshirou
Takikawa, Hajime
Kato, Takeyuki
Chosa, Masayuki
Sunaya, Toshiyuki
Yamamoto, Yuka
Hamada, Yoko
Watanabe, Toshiaki
Sugihara, Kenichi
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
[25] Safety and Effectiveness of Eculizumab for Patients with Generalized Myasthenia Gravis in Japan: Interim Analysis of Post-Marketing Surveillance
Murai, H.
Suzuki, S.
Hasebe, M.
Fukamizu, Y.
Rodrigues, E.
Utsugisawa, K.
EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 485 - 486
[26] Safety and effectiveness of nivolumab in Japanese patients with malignant melanoma: Final analysis of a post-marketing surveillance
Uhara, Hisashi
Tsuchida, Tetsuya
Kiyohara, Yoshio
Akamatsu, Ayumi
Sakamoto, Takahiko
Yamazaki, Naoya
JOURNAL OF DERMATOLOGY, 2022, 49 (09): : 862 - 871
[27] Safety and Efficacy of Ripasudil in Japanese Patients with Glaucoma or Ocular Hypertension: 3-month Interim Analysis of ROCK-J, a Post-Marketing Surveillance Study
Tanihara, Hidenobu
Kakuda, Takahiko
Sano, Tetsuro
Kanno, Takashi
Imada, Ryosuke
Shingaki, Wataru
Gunji, Ryoji
ADVANCES IN THERAPY, 2019, 36 (02) : 333 - 343
[28] Safety and effectiveness of ustekinumab in Crohn's disease: Interim results of post-marketing surveillance in Japan
Yokoyama, Seiji
Asano, Teita
Nagano, Katsumasa
Tsuchiya, Hiroaki
Takagishi, Masayuki
Tsujioka, Shigeharu
Miura, Naomi
Matsumoto, Takayuki
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (11) : 3069 - 3076
[29] Safety and Effectiveness of Satralizumab in Japanese Patients with Neuromyelitis Optica Spectrum Disorder: A 6-month Interim Analysis of Post-marketing Surveillance
Yamamura, Takashi
Isobe, Noriko
Kawachi, Izumi
Nohara, Chiyoko
Miyazaki, Yusei
Tomita, Minami
Tsumuraya, Takahiko
Yamashita, Katsuhisa
Nakahara, Jin
Nakashima, Ichiro
Fujihara, Kazuo
NEUROLOGY AND THERAPY, 2024, 13 (05) : 1361 - 1383
[30] Safety and Effectiveness of Elotuzumab in Japanese Patients with Relapsed/Refractory Multiple Myeloma: A Post-marketing Surveillance Study
Kaneko, Fumiya
Suzuka, Hiroshi
Yoshino, Tomoaki
Hinosugi, Ryosuke
INTERNAL MEDICINE, 2024, 63 (22) : 3039 - 3048

← 1 2 3 4 5 →